People with diabetes may use insulin pens, wearable pump devices, or a glass vial and syringe to deliver this needed medication. Costs vary depending on which method you choose. The price of ...

Purpose: The pharmacology, pharmacokinetics, efficacy and tolerability, safety, drug interactions, dosage and administration, cost, and place in therapy of insulin detemir are reviewed.

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

His medical team agreed he was doomed. But then, Thompson received two injections of an experimental intervention— insulin. Within a day, his blood glucose levels stabilized. A lifesaving drug was ...

Sanjay Basu, Waymark, San Francisco, California. Kasia J. Lipska, Yale University. Insulin is considered an essential medicine for people with diabetes, but its price has doubled during the past ...

(Bloomberg) -- Novo Nordisk A/S’s decision to stop making insulin pens will narrow treatment options for children with diabetes unless non-patented drugmakers such as Biocon Ltd. step in to plug ...

The study, titled "Deubiquitinating Enzymes Regulate Skeletal Muscle Mitochondrial Quality Control and Insulin Sensitivity in Patients with Type 2 Diabetes," was recently published in the Journal ...

a DB = double-blind, DM = diabetes mellitus, HbA 1c = glycosylated hemoglobin, MC = multicenter, NPH = isophane insulin human, NR = not recorded, OL = open-label, PG = parallel-group, R = randomized.

Novo launched the NovoPen - the first insulin pen device in 1985. Lars Rebien Sorensen becomes CEO after serving as the head of Novo's healthcare business. The company's enzymes business was spun ...

Prescriptions for the insulin glargine biosimilar Semglee increased after it was granted interchangeable status with its reference product, Lantus. Increases were seen across retail, mail order ...